The impacts of Pharmaceutical Care in an emergency unit of a teaching hospital

Not Applicable

• Conditions: Clinical Medicine; N02.421.297.195

• Registration Number: RBR-7s755rt
• Lead Sponsor: Faculdade de Ciências Farmacêuticas de Ribeirão Preto da Universidade de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-05-24
• Last Update Posted: 29 May 2023
• Study Completion: 2024-04-30

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

18 years of age or older; both genders; hospital admission carried out by the medical clinic team; admission between 12pm on Sunday and 12pm on Thursday; patient not coming from the clinical stabilisation room, polytrauma, COVID bed and respiratory or contact isolation; not being in contact isolation; stay in the sector for at least 24 hours after admission; admission has not occurred more than 48 hours ago; registration in the medical record of at least one medication for continuous use on admission; not being described in the medical record that the patient will be discharged, has an accepted bed or is being requested a transfer bed to another sector other than the internal medicine ward; possibility of collecting information due to the ability to communicate and remember the medications for continuous use, the presence of the list or packaging of medication or the presence of a caregiver to acquire the information; not being described in medical records that there was medication reconciliation conducted by pharmacists in the sector before the survey; patient consent to participate in the study by signing the Informed Consent Form

Exclusion Criteria

Give up participating in the research before its end

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluate the frequency of mortality in both groups within up to six months after the date of hospital admission on which the patient was included in the study, through medical records and/or telephone contact. The percentage of mortality will be calculated by the ratio between the number of deaths and the number of patients in each group (intervention and control). Pharmacist intervention is expected to decrease the percentage of deaths in the intervention group compared to the control group. Comparison between groups will be performed by statistical analysis, adopting a significance level of 5% and a confidence interval of 95%.